These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 11456381

  • 1. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN.
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS.
    J Clin Oncol; 2002 Jan 01; 20(1):189-96. PubMed ID: 11773169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug 29; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract] [Full Text] [Related]

  • 7. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, Hartnett S, Ferency S, Addison SJ, Appelbaum F.
    J Nucl Med; 1993 Jul 29; 34(7):1031-6. PubMed ID: 7686217
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY, Zhu BL, Zhang YJ.
    Zhonghua Zhong Liu Za Zhi; 1994 Mar 29; 16(2):118-21. PubMed ID: 7523052
    [Abstract] [Full Text] [Related]

  • 11. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay RF, Hoffman RF, Claringbold PG.
    Eur J Nucl Med; 1989 Mar 29; 15(12):784-95. PubMed ID: 2483138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
    Sinzinger H, Weiss K, Hiltunen J.
    Anticancer Res; 2009 Aug 29; 29(8):3393-5. PubMed ID: 19661362
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.
    Tian JH, Zhang JM, Hou QT, Oyang QH, Wang JM, Luan ZS, Chuan L, He YJ.
    Eur J Nucl Med; 1999 Jan 29; 26(1):2-7. PubMed ID: 9933654
    [Abstract] [Full Text] [Related]

  • 16. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P.
    Expert Opin Pharmacother; 2006 Aug 29; 7(11):1475-86. PubMed ID: 16859431
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.
    Bianchi L, Baroli A, Marzoli L, Verusio C, Chiesa C, Pozzi L.
    Eur J Nucl Med Mol Imaging; 2009 Jan 29; 36(1):122-9. PubMed ID: 18751975
    [Abstract] [Full Text] [Related]

  • 20. Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.
    Bruland OS, Skretting A, Solheim OP, Aas M.
    Acta Oncol; 1996 Jan 29; 35(3):381-4. PubMed ID: 8679270
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.